Abstract:Growing numbers of synthetic chemicals have potential endocrine-disrupting effects and cause potential ecological and health risks. However, the primary toxicity pathways and mechanisms of endocrine disruption are poorly understood and the existing risk assessment relies heavily on animal testing. Database mining, omics technology, and computer simulation can serve as an alternative approach to explore the mechanisms by building adverse outcome pathways (AOPs). The present study took a case of thyroid interference with triphenyl phosphate (TPP) to explain the potential toxic effects at levels from submolecules to cells utilizing the AOP framework developed by multiple techniques. This study retrieved the data from a comparative toxicogenomics database (CTD) and screened out the core gene. Molecular dynamics (MD) analysis was used to explore configuration changes and confirm the molecular initiating event (MIE). The transcriptomic analysis was further utilized to supplement the relationships between MIEs and key events (KEs) of the AOP. The thyroid hormone receptor beta (THRB) was identified as the core gene at submolecular levels. MD analysis found that the configuration changes of C-terminal helix 12 (H12) of thyroid hormone receptor β (TRβ) were discovered as the MIE. The transcriptomic analysis extended the related KE1 at the subcellular level, such as changes in gene expression levels for coding cycle regulation (CCND1), inflammatory response (IL1A and IL6), and cell proliferation and apoptosis (BAD, TP53, and CASP9). Then, the KE2 at cellular levels such as apoptosis, cell cycle control, and cell proliferation were influenced accordingly. As a result, these alterations led to thyroid disorder as adverse outcomes. This study provided an efficient way to facilitate the complement of possible AOPs and brought new insights into understanding the toxic mechanisms of emerging synthetic chemicals.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acssuschemeng.0c09196?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acssuschemeng.0c09196</a>.Additional information about materials and methods. Transcriptional responses and pathway analysis (<a class="ext-link" href="/doi/suppl/10.1021/acssuschemeng.0c09196/suppl_file/sc0c09196_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro

A toxicity pathway-oriented approach to develop adverse outcome pathway: AHR activation as a case study

A high-throughput approach to identify specific neurotoxicants/ developmental toxicants in human neuronal cell function assays

Developmental neurotoxicity evaluation of three Chinese herbal medicines in zebrafish larvae by means of two behavioral assays: touch-evoked response and light/dark transition

Nephrotoxicity assessment of podophyllotoxin-induced rats by regulating PI3K/Akt/mTOR-Nrf2/HO1 pathway in view of toxicological evidence chain (TEC) concept

Assessing developmental neurotoxicity of emerging environmental chemicals using multiple in vitro models: A comparative analysis

Integrated Approach for Testing and Assessment for Developmental Neurotoxicity (DNT) to Prioritize Aromatic Organophosphorus Flame Retardants

Neuronal differentiation pathways and compound-induced developmental neurotoxicity in the human neural progenitor cell test (hNPT) revealed by RNA-seq

The adverse outcome pathway concept: a pragmatic tool in toxicology

Prediction of the Neurotoxic Potential of Chemicals Based on Modelling of Molecular Initiating Events Upstream of the Adverse Outcome Pathways of (Developmental) Neurotoxicity

Proof of concept for quantitative adverse outcome pathway modeling of chronic toxicity in repeated exposure

A Toxicity Pathway-Based Approach for Modeling the Mode of Action Framework of Lead-Induced Neurotoxicity.

Identifying Bioaccessible Suspect Toxicants in Sediment Using Adverse Outcome Pathway Directed Analysis.

Adverse outcome pathways: opportunities, limitations and open questions

Development of an adverse outcome pathway network for nephrotoxicity

Developing adverse outcome pathways on silver nanoparticle-induced reproductive toxicity via oxidative stress in the nematode Caenorhabditis elegans using a Bayesian network model

Integration of Computational Toxicology, Toxicogenomics Data Mining, and Omics Techniques to Unveil Toxicity Pathways

AOP report: Development of an adverse outcome pathway for deposition of energy leading to learning and memory impairment

Potential adverse outcome pathways with hazard identification of organophosphate esters

Prediction of Zebrafish Embryonic Developmental Toxicity by Integrating Omics with Adverse Outcome Pathway.